TL;DR:
- Mohs micrographic surgery examines the full margin of each layer under the microscope during the procedure, which spares healthy tissue. It is especially useful for high-risk or sensitive areas. However, clinical judgement and individual circumstances should guide the decision between Mohs and standard excision.
Not all skin cancer operations are the same. Many patients arrive at their first consultation believing that surgery is surgery, and that as long as the cancer is “cut out,” the outcome will be fine. In reality, the technique your surgeon uses affects how the margins are checked and how much healthy tissue is removed. Mohs micrographic surgery checks the whole margin of each layer under the microscope during the procedure, before the wound is closed. This guide explains how it works, where it is used and when standard excision is the better choice.
Key Takeaways
| Point | Details |
|---|---|
| Mohs checks every margin | This technique checks the tissue margins during surgery, so further tissue is taken only where cancer remains. |
| Used for sensitive areas | Mohs is especially useful where preserving function and appearance matters, such as the face and hands. |
| Not always the only choice | Mohs isn’t necessary for every case; other methods suit many straightforward skin cancers. |
| Why it is called the gold standard | Published five-year cure rates for Mohs are around 99% for primary basal cell carcinoma (StatPearls, NIH), and it spares healthy tissue. |
What does ‘gold standard’ mean in skin cancer surgery?
To understand why Mohs stands out, we first need to define what a ‘gold standard’ treatment actually involves. In medicine, a gold standard is the treatment that newer approaches are measured against: one that has been studied repeatedly and is widely used as the benchmark.
In skin cancer surgery specifically, a gold standard technique must satisfy several demanding criteria:
- Complete removal of the cancer, including for aggressive or recurrent tumours
- Minimal removal of healthy tissue, reducing the size of the wound and the complexity of reconstruction
- Protecting function and appearance, particularly where tissue loss would affect movement or appearance
- Adaptability, meaning the approach works for tumours in awkward anatomical positions or with unpredictable growth patterns
- Reliable real-time margin assessment, so the surgeon knows at the time of the operation whether any cancer cells remain
Recurrence rates are one of the clearest measures of how well a technique clears a cancer. Staged excision with immediate microscopic examination allows repeat removal only where cancer persists, which keeps the wound as small as possible in sensitive anatomical sites.
When you hear the phrase ‘gold standard’ applied to what is Mohs surgery, it refers to two things: the whole margin is examined during the procedure, and published five-year cure rates are around 99% for primary basal cell carcinoma and 94.4% for recurrent basal cell carcinoma (StatPearls, NIH).
How does Mohs surgery check that the cancer has gone?
The Mohs process follows a carefully structured sequence that is fundamentally different from taking out a tumour and sending the specimen to an external laboratory:
- Initial removal: The surgeon removes the visible tumour along with a thin margin of surrounding tissue, keeping the excision as conservative as possible.
- Margin mapping: The tissue is divided into sections and mapped precisely, so that every edge of the specimen corresponds to a known location on the patient’s skin.
- On-site microscopy: A pathology technician processes the specimen in the operating suite or adjacent laboratory, and the surgeon personally examines the tissue under a microscope.
- Targeted re-excision: If cancer cells appear at any margin, only that precise zone is removed. Healthy areas are left in place.
- Repetition until clear: Stages continue until all margins are confirmed cancer-free, at which point reconstruction begins.
Because every edge is examined before the wound is closed, further tissue is removed only where cancer remains. A standard excision is sent to an external laboratory and checked days later, usually by sampling sections of the edge.
The table below shows how the two techniques differ:
| Feature | Standard excision | Mohs micrographic surgery |
|---|---|---|
| Margin assessment | Sample only (not full margin) | 100% of margin examined |
| Tissue removed | A fixed margin around the tumour | Further tissue only where cancer remains |
| Real-time feedback | No (days to result) | Yes (same day) |
| Typical use | Most low-risk skin cancers | High-risk tumours and sensitive sites such as the face |
| Reconstruction timing | Usually immediate | Same-day when clear |
The difference in margin assessment is especially important. Standard excision typically examines only a small percentage of the cut edges. If cancer cells happen to be present at a section that was not sampled, neither the surgeon nor the pathologist will know. With Mohs, the whole edge is examined during the procedure, so any cancer left at the edge is found before the wound is closed.
You can read a detailed walkthrough of the procedure in this basal cell removal guide, which also covers what to expect at each stage of your surgical day.
Pro Tip: When speaking to a surgeon about Mohs, ask specifically how margin assessment is performed. True Mohs surgery means the entire circumferential and deep margin is examined, not just representative sections. Some clinics describe “Mohs-like” approaches that do not include full mapping, so it is worth clarifying before you commit.
Understanding the anatomy of your tumour is also part of effective planning. Skin cancer mapping before surgery gives both you and your surgeon a clearer picture of how the tumour is growing and why its edges may not be predictable from what is visible on the surface.
Why Mohs is preferred for sensitive and high-stakes sites
Mohs is used most often where the position of the tumour makes tissue loss harder to repair.
Skin cancer does not choose its location based on surgical convenience. A basal cell carcinoma sitting on the nose, the inner corner of an eye, the ear canal, the lip, or the back of the hand creates an entirely different clinical challenge compared to a small lesion on the upper back. In those high-stakes positions, every millimetre of healthy tissue that can be preserved directly affects what you will look like, how you will breathe through your nose, or whether your eyelid closes properly.
Mohs is recommended for aggressive infiltrating tumours or tumours in cosmetically and functionally sensitive areas, including the head and neck, hands and feet, and genitalia. This recommendation exists because the consequences of incomplete clearance or excessive tissue sacrifice in these regions are disproportionately severe.
The benefits in sensitive anatomical sites include:
- A smaller wound: By removing only what is demonstrably cancerous, the resulting wound is as small as it can be, which can make reconstruction simpler
- Maintained movement and sensation: Structures like muscles, nerves, and cartilage are exposed only where necessary
- Planned reconstruction: Because the defect is precisely defined after the final stage, reconstruction after Mohs surgery can be planned around the exact size and shape of the defect
- Clearing the cancer at the first operation: Re-excision of a recurrent tumour near the eye or nose is more difficult, which is why the margin is checked before the wound is closed
The table below shows how the choice usually differs by tumour site:
| Tumour location | Standard excision | Mohs surgery |
|---|---|---|
| Face (nose, eyelids, lips) | A wider margin is usually needed to allow for unseen spread | Used for many tumours here, because it spares healthy tissue |
| Ears and scalp | Often suitable for low-risk lesions | Used for morphoeic or other aggressive types |
| Hands and feet | Wide margins can affect function | Used where healthy tissue needs to be spared |
| Trunk and upper limbs | Often appropriate and cost-effective | Usually reserved for high-risk histology only |
For a more detailed discussion of why Mohs for facial skin cancer is so frequently recommended, including how it compares to other methods in real clinical decision-making, you will find a focused explanation that helps put your own situation into context.
Are there limitations or drawbacks to Mohs?
Mohs is not the automatic right answer for every skin cancer diagnosis. The technique requires a specialist surgeon trained specifically in the procedure, an on-site histopathology service, and typically a longer procedure day than a standard excision under local anaesthetic. For many patients, particularly those with small, well-defined, low-risk cancers on non-cosmetically sensitive areas, standard excision by an experienced surgeon is usually the right choice, at a lower cost and with less complexity.
Situations where standard excision may be the more appropriate choice include:
- Small, nodular basal cell carcinomas on the trunk or limbs where the borders are clear and the risk of aggressive infiltration is low
- Patients with limited access to a Mohs-trained surgeon in their region, where the delay in receiving Mohs care would itself pose a clinical risk
- Squamous cell carcinomas in very low-risk anatomical sites with no evidence of perineural invasion or other aggressive features
- Patients where the procedure time would be clinically hazardous due to complicating health factors
From a financial perspective, cost-effectiveness analyses do not always favour Mohs over standard excision depending on context and the assumptions applied, even when the clinical performance in terms of margin control and cure rates is strong. This does not diminish the value of Mohs for appropriate candidates, but it does underline why the decision should be made with expert guidance rather than assumed.
You can find a direct comparison of the two approaches in this Mohs vs standard excision guide, which covers the clinical and practical factors that influence the recommendation. If you have come across conflicting information or feel uncertain about what you have been told, the Mohs myths and facts resource addresses the most common misconceptions directly.
Pro Tip: The question to ask your specialist is not simply “Is Mohs better?” but “Is Mohs better for my specific tumour, in my specific location, given my health and priorities?” That nuance is where genuine clinical expertise earns its value.
Why the gold standard label still matters
The phrase ‘gold standard’ risks becoming background noise if it is applied too liberally. It is attached to everything from dietary supplements to dental implants. What keeps it meaningful in the context of Mohs surgery is that it is earned through verifiable performance, not marketing.
Take a morphoeic basal cell carcinoma on the tip of the nose. Its surface can understate how far it extends beneath the skin. Excision guided by the visible edge alone risks either leaving cancer behind or removing more tissue than necessary. Mohs follows the tumour layer by layer, checking each edge under the microscope before any more tissue is taken.
At the same time, the gold standard label should never override individualised judgement. For some patients the most clinically sound choice is a carefully performed standard excision, because the tumour type, site and circumstances make it the right one. A surgeon who recommends Mohs for every lesion regardless of clinical need is not practising gold standard medicine. They are confusing the technique with the principle.
The true mark of quality in skin cancer surgery is collaborative, transparent decision-making. That means a specialist who listens to your priorities, explains the evidence, and recommends the approach that genuinely serves your interests. Whether the outcome involves Mohs, standard excision, or a combination with plastic surgery after Mohs, the goal remains consistent: complete tumour clearance and a repair planned around your own anatomy.
How to arrange a consultation with Miss Rakhee Nayar
Miss Rakhee Nayar is a Consultant Plastic Surgeon and Mohs surgeon, and one of fewer than 10 women in the UK dual-trained in both plastic surgery and Mohs micrographic surgery. She carries out Mohs surgery and the facial reconstruction that follows it. If you are at the stage of wanting a formal assessment, the skin cancer detection service is the right place to begin. To arrange a consultation at Circle Cheshire Clinic in Northwich or Fairfield Independent Hospital in St Helens, send an enquiry or call Lisa, Miss Nayar’s secretary, on 07740 306144. There is no charge for an enquiry and no obligation to book.
Frequently asked questions
Is Mohs surgery more successful than standard skin cancer removal?
Mohs surgery examines the whole margin under the microscope during the procedure and removes more tissue only where cancer remains. That is why it is used for complex or high-risk cases, where clearing the cancer at the first attempt matters most.
Will Mohs leave a visible scar on my face?
Any surgery leaves a scar. Mohs removes as little healthy tissue as possible, so the wound to be repaired is as small as it can be. How the scar looks depends on the site, the size of the wound and how it is repaired.
Why isn’t Mohs recommended for every skin cancer?
Mohs is most beneficial for aggressive, recurrent, or anatomically sensitive tumours; many small, low-risk cancers on the trunk or limbs respond equally well to standard excision without the additional complexity or cost that Mohs involves.
Is Mohs cost-effective compared to other methods?
Cost-effectiveness analyses do not always favour Mohs over standard excision, particularly for lower-risk presentations, which is why clinical suitability rather than technique preference alone should guide the choice of treatment.
Recommended
- Why choose Mohs surgery for facial skin cancer removal?
- Mohs vs standard excision: what matters for your care
- Mohs surgery myths vs facts: what patients need to know
- What is Mohs Micrographic Surgery? | Miss Rakhee Nayar
Filed under Mohs Surgery
